Package 0615-8007-14

{"route": ["ORAL"], "spl_id": "77d8e3d2-c909-4c76-9572-f838179cd722", "openfda": {"unii": ["YRZ789OWMI"], "rxcui": ["259255", "617310"], "spl_set_id": ["7353f9ef-6f79-4522-886a-7a8ae4eb867e"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, FILM COATED in 1 BLISTER PACK (0615-8007-05)", "package_ndc": "0615-8007-05", "marketing_start_date": "20120529"}, {"sample": false, "description": "7 TABLET, FILM COATED in 1 BLISTER PACK (0615-8007-07)", "package_ndc": "0615-8007-07", "marketing_start_date": "20181109"}, {"sample": false, "description": "14 TABLET, FILM COATED in 1 BLISTER PACK (0615-8007-14)", "package_ndc": "0615-8007-14", "marketing_start_date": "20221213"}, {"sample": false, "description": "28 TABLET, FILM COATED in 1 BLISTER PACK (0615-8007-28)", "package_ndc": "0615-8007-28", "marketing_start_date": "20250108"}, {"sample": false, "description": "6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8007-30)  / 5 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0615-8007-30", "marketing_start_date": "20120529"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8007-39)", "package_ndc": "0615-8007-39", "marketing_start_date": "20120529"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "0615-8007_77d8e3d2-c909-4c76-9572-f838179cd722", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "0615-8007", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE", "strength": "20 mg/1"}], "application_number": "ANDA090548", "marketing_category": "ANDA", "marketing_start_date": "20120529", "listing_expiration_date": "20261231"}